home
           
   
   Corepressor Antibodies – The Sound of Silence
   
       
       
  
   
   

Please click here if this newsletter is not displayed properly!

Important note: If you have questions, comments or want to get in contact with us directly, please DO NOT reply to this newsletter. Please send your inquiry to info@jenabioscience.com.

   
   

NCoR and SMRT are well-known corepressors crucial for the assembly of functional holocomplexes that lead to gene silencing [1-3]. Listen to the sound of silence with our well-established NCoR and SMRT antibodies.

Due to their pivotal role in histone modification and chromatin remodeling, NCoR and SMRT have gained tremendous importance in the field of Epigenetics in recent years [4]. They are well-known corepressors of nuclear receptors but interactions have been shown with various protein families:

Our NCoR and SMRT antibodies are convenient tools for studying corepressor complexes and the corresponding pathways. They are suitable for Western Blot analyses, Immunoprecipitation (IP), Chromatin Immunoprecipitation (ChIP) and Immunohistochemistry [5]. Anti-NCoR has been successfully applied in precipitation of HDACs e.g. for HDAC activity assays [6].




References:
[1] Rosenfeld et al. (2006) Sensors and signals: a coactivator / corepressor / epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20:1405.
[2] Heinzel et al. (1997) A complex containing N-CoR, mSln3 and histone deacetylase mediates transcriptional repression. Nature 387:43.
[3] Nagy et al. (1997) Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373.
[4] Perissi et al. (2010) Deconstructing repression: evolving models of co-repressor action. Nat. Rev. Genet. 11 (2):109.
[5] Tiefenbach et al. (2006) SUMOylation of the Corepressor N-CoR Modulates Its Capacity to Repress Transcription. Mol. Biol. Cell. 17:1643.
[6] Göttlicher et al. (2001) Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J. 20 (24):6969.


   
   

If you wish not to receive further email newsletters from us, please reply to this E-mail with the subject "UNSUBSCRIBE" or unsubscribe via the form at our website at www.jenabioscience.com.
 

   
   
   
   Responsible for content / Imprint
   
Jena Bioscience GmbH
Loebstedter Str. 80
07749 Jena
Germany

Phone:+49 – 3641 – 6285 000
Fax: +49 – 3641 – 6285 100
E-Mail: info@jenabioscience.com

Register Court: Amtsgericht Jena, HRB 207171
VAT No.: DE 195825742

Managing Directors:
Thomas Billert
Dr. Mathias Grün
   
           
    www.jenabioscience.com   
           
      © 2010 Jena Bioscience GmbH - Imprint